Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins.

Saved in:

Bibliographic Details
Title:	Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins.
Authors:	O'Donnell KL; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States., Gourdine T; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States., Fletcher P; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States., Clancy CS; Rocky Mountain Veterinary Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States., Marzi A; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States.
Source:	Frontiers in immunology [Front Immunol] 2022 Oct 24; Vol. 13, pp. 1025500. Date of Electronic Publication: 2022 Oct 24 (Print Publication: 2022).
Publication Type:	Journal Article; Research Support, N.I.H., Intramural
Journal Info:	Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1664-3224
DOI:	10.3389/fimmu.2022.1025500